startups that combine global pharmaceutical expertise with cutting-edge AI and biotechnology. This approach reduces risk by fostering cross-industry partnerships, enabling seamless data sharing, and providing unparalleled access to pharma R&D expertise.

Our model accelerates the path to market for startups, empowering them to create and validate transformative solutions for the biotech industry. To date, AION Labs has launched and invested in nine innovative startups, led by visionary founders, driving an AI-powered revolution in biotech.